Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- MHLW to Draw Up Guideline for Collecting Plasma from People Recovering from Emerging Infectious Diseases
December 22, 2020
- MHLW Urges Drug Makers to Provide Timely, Appropriate Information When Product Shortages Occur
December 22, 2020
- Advisory Panel Shelves Decision on Avigan, Says No Clear Efficacy Shown for COVID-19
December 22, 2020
- Japan Govt to Compile Formulary Guidelines by FY2022: Reform Timeline
December 21, 2020
- Japan Saves 431.5 Billion Yen in Drug Price Cuts, Curbs Social Security Costs: FY2021 Draft Budget
December 21, 2020
- Next New Drug Listing Scheduled for Next April: MHLW
December 21, 2020
- Chuikyo OKs Outline of FY2021 Off-Year Re-Pricing; Only Market Price-Linked Rules to Be Applied
December 21, 2020
- PMDA Reviewing Safety Risks for Pomalyst, MabCampath
December 21, 2020
- Ministers Agree on 5%-Plus Price Discrepancy Line for Off-Year Re-Pricing; 59% Coverage for Innovative Meds, 88% for LLPs, 83% for Gx
December 18, 2020
- Avigan’s COVID-19 Use Up for PAFSC Review on December 21
December 17, 2020
- MHLW Earmarks 3 Billion Yen in FY2020 Extra Budget to Support Construction of API Facilities
December 17, 2020
- Govt Settles on Discrepancy Rate Threshold of “Above 5%” for Off-Year Drug Re-Pricing, 430 Billion Yen Reduction, 60% Coverage for Innovative Meds
December 17, 2020
- Japan Govt Eyes 4-6% Price Discrepancy Threshold for Off-Year Drug Re-Pricing
December 16, 2020
- Avigan to Come Up for PAFSC Review This Month
December 16, 2020
- Govt to Set 2 Million Yen Income Threshold for Elderly Copay Raise
December 16, 2020
- Govt Wants Chuikyo to Work Out Policies on Insurance Coverage for Infertility Treatments in Early 2022
December 16, 2020
- AMED’s Private Information on 1,400 Employees Might Be Leaked due to Unauthorized Access
December 16, 2020
- MHLW Urges Drug Makers to Boost Manufacturing Control after Itraconazole Issue
December 15, 2020
- No Plan to Investigate Efficacy of Japanese Encephalitis Vaccines against COVID-19: Govt
December 15, 2020
- Japan to Prioritize COVID-19 Vaccinations for Doctors, Staffers in Frequent Contact with Infected Patients
December 15, 2020
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…